The Inaugural MedFemTech Congress

Palais des Congres, Paris, France | May 9-10, 2023

Promoting emerging medical solutions for women to improve diagnostics and treatment

Registration for start-up companies

Registration for individuals

Founding Partners

Knowledge Partner

MedFemTech Congress

The idea behind this congress is to promote emerging medical solutions for women to improve diagnostics and treatment.

We wish to connect and engage key players in the female medical technology sector, launching a global community of medical professionals, innovators, investors, and other experts from across the healthcare ecosystem – from doctors to investors, career medical professionals, and tech visionaries – representing hospitals, clinics, academia, and technology solution companies.

Learn more

Get in touch

Tailored Package for Start-up Companies

Download the prospectus

$25.1B

Market today

$60.1B

Market projection by 2027

1,500

Start-up companies

The Problems Today

Historical bias against women in medical research and care which only in recent years has been recognized and is starting to be addressed

Abundance of tech / consumer players who self label as FemTech however lack or overlook scientific rigor in their product or approach

Knowledge gap of treating physicians about innovations in the space and the ability to screen innovating products

The Opportunity

The overall FemTech market was valued at $18.7B in 2019 and is projected to reach $60.1B by 2027, with a CAGR of over 15.6%. The industry still remains underestimated

Over 1,500 companies have been classified as FemTech, categorized into 14 subsectors and 8 aggregated subsectors by application. Accounting for 21.8% of the total market, pregnancy is the largest followed by longevity and fertility, accounting for 13.1% each

Our Unique Structure & Program

Our unique program structure composed of:

2 day scientific program focusing on the main medical challenges facing women

Each topic headlines by a medical presentation and followed by 5-10 brief ‘lighting talks’ of start-ups focusing in this area

50-100 exhibitors with focus on start-up companies

Networking & individual meetings between investors/industry and start ups

Global exposure via Forbes ‘spotlight’ interview for selected top ~10 start-ups

An extensive participant directory

Download the Program

Congress Registration

Registration for start-up companies

Prospectus download

Click to register

Tailored Package for Start-up Companies: € 2,000

A chance to be selected for a 10-minute presentation, scheduled in the program presenting the company’s innovation

4 complimentary delegate passes

Delegate list

Access to the congress software to schedule on-site meetings

Logo and short company profile on congress website

Additional benefit € 500

6 sqm space provided

Click to register – start-up companies

Registration for individuals

Click to register

EARLY REGISTRATION

If registered by 09/03/2023
€ 500

Learn more

LATE REGISTRATION

If registered by 01/05/2023
€ 650

Learn more

ONSITE REGISTRATION

From 02/05/2023
€ 750

Learn more

Click to register – individuals

Registration for industry delegates

Click to register

EARLY REGISTRATION

If registered by 09/03/2023
€ 800

Learn more

LATE REGISTRATION

If registered by 01/05/2023
€ 900

Learn more

ONSITE REGISTRATION

From 02/05/2023
€ 1,000

Learn more

Click to register – industry delegates

More information

IMPORTANT:
Once you are registered to the MedFemTech Congress, please note that you agree to receive promotional material and updates regarding the Congress.

Payment
Payment of registration fees can be made through this website using a credit card or by bank transfer.
Payment by bank transfer – all transaction fees should be paid by the registrant.

Cancellation Policy
All cancellations must be faxed, electronically mailed, or postmarked. Refund of registration fees will be as follows:
Postmarked up until March 09, 2023 – 100% refund (minus € 50 handling fee and bank charges)
Postmarked from March 10, 2023 – 50% refund
No refund on cancellations sent after May 1, 2023

Liability
The Congress Secretariat and Organizers cannot accept liability for personal accidents, sickness, and cancellations by any party, nor loss of or damage to private property of participants, either during or directly arising from the MedFemTech Congress.
Participants should make their own arrangements with respect to health and travel insurance.

For further information regarding registration, please contact:
Einat Gassner Gutman
Senior Registration & Accommodation Manager
[email protected]

Press

MedFemTech Forbes article EN

MedFemTech Forbes article FR

Founding Members

Prof. Zeev Shoham (IVF-Worldwide)
Prof. Milton Leong (IVF-Worldwide)
Prof. Ran Balicer (Chief Innovation Officer, Clalit Health Services, IL)
Mr. Dominique Busso (Forbes)
Ms. Gila Tolub (McKinsey & Company)
Ms. Marie Busson (McKinsey & Company)
Tiffany Starr McKever (Founder and Chief Strategist, Consensus Healthcare Consultants)

Advisory Board

Maura Rosenfeld, MindUp
Marija Butkovic, Women of Wearables
Navneet Kaur, FemTech India
Reenita Das, Frost & Sullivan

Scientific and Medical Board

Prof. Yesha Sivan, DigitalRosh
Itamar Netzer, MD MBA, OB/GYN, Medical Administration specialist, Clalit
Dr. Stasa Stankovic, University of Cambridge
Noemie Elhadad, PhD, Columbia University
Prof. Jennifer Garrison
Prof. Antonio Pellicer, the ‘IVI Foundation’ and ‘Equipo IVI’
Prof. Gerald Schatten, Pittsburgh Development Center